A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor

Brook E. Heaton, Edward M. Kennedy, Rebekah E. Dumm, +4

Cell Reports

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

Tomer M. Yaron, Brook E. Heaton, Tyler Levy, +44

Science Signaling

Viral ReplicationSignal TransductionVaccine DevelopmentHost Protein KinasesReceptor Tyrosine Kinase +12

Control of antiviral innate immune response by protein geranylgeranylation

Shigao Yang, Alfred T. Harding, Catherine Sweeney, +14

Science Advances

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

Tomer M. Yaron, Brook E. Heaton, Tyler Levy, +42

GPER1 is required to protect fetal health from maternal inflammation

Alfred T. Harding, Marisa Goff, Heather M. Froggatt, +2

Science

Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs

Alfred T. Harding, Brook E. Heaton, Rebekah E. Dumm, +1

mBio

Rapid tissue prototyping with micro-organospheres

Zhaohui Wang, Matteo Boretto, Rosemary Millen, +35

Stem Cell Reports

Tissue EngineeringRapid TissueEngineeringBiofabricationOrgan-on-a-chip +3

ETV7 limits antiviral gene expression and control of influenza viruses

Heather M. Froggatt, Alfred T. Harding, Ryan R. Chaparian, +1

Science Signaling

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2

Tomer M. Yaron, Brook E. Heaton, Tyler Levy, +42

Viral ReplicationSrpk1/2-targeted TherapiesSignal TransductionKinase Srpk1Immunology +12

A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice

Ryan R. Chaparian, Alfred T. Harding, Cait E. Hamele, +5

Journal of Virology